TMLHE


Description

The TMLHE (trimethyllysine hydroxylase, epsilon) is a protein-coding gene located on chromosome X.

The TMLHE gene, located on chromosome X, encodes a mitochondrial enzyme called trimethyllysine dioxygenase. This enzyme plays a critical role in carnitine biosynthesis, a pathway essential for the transport of fatty acids within cells. Mutations in the TMLHE gene can lead to carnitine biosynthesis disruption, which has been linked to autism symptoms.

Structure: TMLHE is located in the mitochondrial matrix, where it acts as a non-heme-ferrous iron hydrolase.

Function: TMLHE catalyzes the first step in the carnitine biosynthesis pathway, converting trimethyllysine (TML) into hydroxytrimethyllysine (HTML). This conversion requires iron and L-ascorbate as cofactors.

Clinical Significance: Mutations in the TMLHE gene can cause epsilon-trimethyllysine hydroxylase deficiency (TMLHED), an inborn error of metabolism affecting carnitine biosynthesis. This deficiency can increase the risk of neurodevelopmental disorders, autism-related behaviors, and autism spectrum disorders.

Interactions: TMLHE is known to interact with 14 other proteins, including 12 co-complex interactions.

TMLHE is also known as AUTSX6, BBOX2, TMLD, TMLH, TMLHED, XAP130.

Associated Diseases


Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.